These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36650669)

  • 1. Evaluating the role of time in range as a glycemic target during short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes.
    Liu L; Ke W; Xu L; Li H; Liu J; Wan X; Liu J; Deng W; Cao X; Xiao H; Li Y
    J Diabetes; 2023 Feb; 15(2):133-144. PubMed ID: 36650669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower mean blood glucose during short-term intensive insulin therapy is associated with long-term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence-based recommendations for standardization.
    Liu L; Liu J; Xu L; Ke W; Wan X; Li H; He X; Wang L; Cao X; Xiao H; Li Y
    J Diabetes Investig; 2018 Jul; 9(4):908-916. PubMed ID: 29193795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes.
    Liu L; Yang S; Liu J; Li H; Liu J; Cao X; Xiao H; Li Y
    J Diabetes Res; 2018; 2018():9423965. PubMed ID: 30581872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients.
    Liu J; Liu J; Fang D; Liu L; Huang Z; Wan X; Cao X; Li Y
    Endocr J; 2013; 60(6):725-32. PubMed ID: 23428844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.].
    Li YB; Zeng LY; Shi LX; Zhu DL; Zhou ZG; Yan L; Tian HM; Luo ZJ; Yang LY; Liu J; Weng JP
    Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):9-13. PubMed ID: 20356473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
    Liu L; Ke W; Wan X; Zhang P; Cao X; Deng W; Li Y
    Diabetes Res Clin Pract; 2015 May; 108(2):250-7. PubMed ID: 25765670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.
    Ryan EA; Imes S; Wallace C
    Diabetes Care; 2004 May; 27(5):1028-32. PubMed ID: 15111515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study.
    Xu W; Li YB; Deng WP; Hao YT; Weng JP
    Chin Med J (Engl); 2009 Nov; 122(21):2554-9. PubMed ID: 19951569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.
    Weng J; Li Y; Xu W; Shi L; Zhang Q; Zhu D; Hu Y; Zhou Z; Yan X; Tian H; Ran X; Luo Z; Xian J; Yan L; Li F; Zeng L; Chen Y; Yang L; Yan S; Liu J; Li M; Fu Z; Cheng H
    Lancet; 2008 May; 371(9626):1753-60. PubMed ID: 18502299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes].
    Li YB; Zhu HL; Yao B; Huang ZM; Ou XZ; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):602-5. PubMed ID: 15949356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.
    Lin S; Chen M; Chen W; Lin K; Mu P; Zhu B; Xu W; Wang M; Weng J; Zeng L
    J Diabetes Res; 2018; 2018():2791584. PubMed ID: 30420969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes.
    Xu L; Zhang P; Huang Z; Zhong L; Li H; Liu L; Liu J; Xiao H; Li Y
    J Diabetes Res; 2020; 2020():4097469. PubMed ID: 32149152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment.
    Chen A; Huang Z; Wan X; Deng W; Wu J; Li L; Cai Q; Xiao H; Li Y
    Diabetes Care; 2012 Mar; 35(3):474-81. PubMed ID: 22228747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.
    Hu Y; Li L; Xu Y; Yu T; Tong G; Huang H; Bi Y; Weng J; Zhu D
    Diabetes Care; 2011 Aug; 34(8):1848-53. PubMed ID: 21680726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
    Liu L; Wan X; Liu J; Huang Z; Cao X; Li Y
    Diabetes Technol Ther; 2012 Sep; 14(9):756-61. PubMed ID: 22731793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
    Li Y; Xu W; Liao Z; Yao B; Chen X; Huang Z; Hu G; Weng J
    Diabetes Care; 2004 Nov; 27(11):2597-602. PubMed ID: 15504992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
    Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
    J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes: efficacy, weight control and safety].
    Xu Y; Wu P; Wen W; Chen H
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1305-1311. PubMed ID: 31852646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.